InspireMD stent shows positive trial results

05/5/2008 | FDAnews

A multicenter trial in Germany found no thrombosis and low incidence of major adverse cardiac events in high-risk patients with complex lesions who received InspireMD Ltd.'s MGuard coronary stent. The device has been approved by European regulators for coronary artery disease treatment.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY